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Abstract
We present a patient diagnosed with a multiple congenital anomaly syndrome
characterized by scoliosis, intellectual disabilities, and craniofacial defects. Trio-based whole
exome sequencing identified compound heterozygous variants in the HSPG2 gene: a maternally
inherited c.5998-7A>G variant in the promoter region and a paternally inherited c.4916C>T
variant in the coding sequence. HSPG2 encodes for perlecan, a large proteoglycan that plays an
important role in cartilage formation, cell adhesion, and basement membrane stability. Mutations
in HSPG2 have been associated with Schwartz-Jampel syndrome and Dyssegmental Dysplasia
Silverman-Handmaker Type, two disorders characterized by skeletal abnormalities (1). These
data indicate a function for HSPG2 in cartilage development/maintenance. However, the
mechanisms by which HSPG2 regulates cartilage development are not completely understood.
To address this, we performed morpholino-mediated knockdown of hspg2 in zebrafish.
Knockdown of hspg2 resulted in a 7% truncation in the mandible and a fusion of the mandibular
jaw point at 5 days post fertilization (dpf). We surmised that defects in mandible development
were a consequence of neural crest cell (NCC) function, as these multipotent progenitors produce
the cartilage of the head and neck. Early NCC development was normal in morphant animals as
measured by dlx2a and sox10 expression at 1 dpf. However, subsequent analysis at later stages
of development (3-4 dpf) revealed a decrease in the number of sox10 and col2a1a positive cells
within the mandibular jaw joint region of morphants relative to control injected embryos.
Concurrently, morphants showed a decreased expression of nkx3.2, a jaw joint molecular marker
at 2 dpf. Collectively, these data suggest a complex role for hspg2 in jaw joint formation and
late stage NCC differentiation.
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Chapter 1: Introduction
MULTIPLE CONGENITAL ANOMALIES
A multiple congenital anomaly (MCA) syndrome is characterized as two or more
differently localized congenital defects in a single individual (2). The congenital defects present
in these cases are classified as either major abnormalities (congenital heart defects) or minor
abnormalities (a single palmar crease). While MCAs are generally rare (about 1-3% of newborns
present with more than one major congenital anomaly at birth), infants with MCAs have longer
hospital stays and increased mortality rates (3). Most congenital malformations observed in the
first year of life (65-75 percent) are classified as having an “unknown” cause. However, even
with such a large portion of congenital anomalies having seemingly unknown causes, these
abnormalities collectively comprise over 15,500 of all recognized genetic disorders (4). While it
is estimated that genetic mutations are the second largest cause of abnormalities (ranging
anywhere from 15-25 percent), it is also likely that a significant proportion of malformations
labeled as “unknown” are likely to have a genetic component as well. (4).
Recognized genetic causes are inherited mutations (which can either be autosomal or Xlinked), de novo mutations (which appear in the individual without a hereditary context),
chromosomal aberrations (which are abnormalities of chromosomal structure), and
microinsertions or deletions (4). Although the interplay between genotype and phenotype is
complex, genetic causes are still a major underlying cause of reported cases and therefore, it is
vital to study the genetic etiology of patients diagnosed with MCAs. By studying the genetic
etiology of patients, research can more readily uncover the mechanisms behind genetic factors
causing disease (4).
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PATIENT CASE

Central to our project is a patient case diagnosed with an MCA of unknown etiology. The
patient presents with craniofacial abnormalities, idiopathic scoliosis, and an intellectual disability
not found in either parent. To examine the patient case, whole exome sequencing (WES) of
patient and related parents was sequenced.
WHOLE EXOME SEQUENCING AS A TOOL TO UNCOVER GENETIC ETIOLOGY

WES is a reliable scientific technique used to examine portions of the genome (5). This
method sequences the exome (the portion of DNA which provides the backbone for creating
functional proteins) because it is the genetic component most likely to give interpretable
mutations that result in phenotypes (6). The mutations most reliably diagnosed by WES are
missense and nonsense variants that are rare in the general population and have been previously
reported as pathogenic, or insertion/deletions smaller than 50 base pairs within non-repetitive
coding DNA (7).
WES is also a readily affordable technique. Initially, sequencing the genome was a
lengthy and expensive endeavor, ranging anywhere from 20-25 million dollars per sample (8).
Fortunately, WES emerged as a next-generation sequencing approach in 2008 and since then has
functioned as a less expensive and rapid alternative to the original procedure (8). WES has most
recently been used in patient cases presenting with craniofacial abnormalities, syndromic
intellectual disabilities, and familial idiopathic scoliosis to identify variants in the EFTUD2,
SNRPA, and HSPG2 genes (9–11).
HSPG2 AND PERLECAN

HSPG2 (heparan sulfate proteoglycan 2) is a gene located on the human short arm p of
chromosome one at position 36.12 (12). HSPG2 encodes for a large, multidomain proteoglycan
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known as perlecan, which, despite its size and general complexity, is well conserved across
various vertebrate species (12). After intracellular modification, perlecan is secreted into the
basement membrane, a region rich with glycoproteins, collagen, and laminins that separates the
epithelium from underlying connective tissue. Perlecan is also found in cartilage, which makes
up most of the skeleton during early development (12,13).
Perlecan consists of five domains. Domain I is unique to perlecan and plays an integral
role in vertebrate tissue integrity and development. This domain consists of a module that shares
homology with the Sperm, Enterokinase, and Agrin (SEA) domain of other extracellular matrix
proteins, and glycosaminoglycan (typically a mixture of heparan sulfate and chondroitin sulfate)
chains which are attached at three sites (14). These chains bind to cellular factors like laminins
and elastins which (respectively) regulate elastic fiber assembly and basement membrane
structure and integrity (14). Domain II is made up of four low-density lipoprotein (LDL)
receptor-like regions and one immunoglobulin (Ig) like repeat. These components bind to
proteins like Fibrillin-1 and provide the cell with proper connective tissue microfibril
organization (14).
Domain III is comprised of three laminin B regions, which break up a longer stretch of
eleven laminin epidermal growth factor (EGF)-like repeats. All vertebrate animals share this
splitting of the EGF-like repeats and homology of this domain ranges from 60 percent up to 90
percent (14). Proteins like WARP bind to the second Laminin EGF-like repeat and mediate the
chondrocyte pericellular matrix (14). Of all the perlecan domains, Domain IV is the most
homogenous, with twenty-one Ig repeats that bind to components like nidogen-1 and collagen IV
which regulate basement membrane integrity. Lastly, Domain V contains three modules with
homology to laminin G chains separated by two EGF-like regions. These components bind to
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proteins like ECM1 and alpha-distroglycan and aid in epithelial cell polarity and basement
membrane organization (14).
MUTATIONS IN HSPG2 DISRUPT SKELETAL DEVELOPMENT
Published works have linked mutations in HSPG2 (most located in what would be
Domains III and IV) to MCAs like Schwartz-Jampel Syndrome (SJS) and Dyssegmental
Dysplasia Silverman-Handmaker Type (DDSH) (15–18). Overwhelmingly, mutations in HSPG2
that lead to reduced levels of normal perlecan secretion into the extracellular matrix are
associated with SJS while functional null mutations in which perlecan is not secreted into the
extracellular matrix are exhibited in DDSH (1). SJS is a rare, autosomal recessive disorder
characterized most notably by muscle stiffness (myotonia) and skeletal abnormalities (19). SJS
Type 1A manifests early with predominately myotonia-related phenotypes while SJS Type 1B
skews towards bone anomalies. SJS is also allelic to DDSH, a less frequent but more severe
autosomal recessive disorder characterized by similar musculoskeletal deformities (19).
While skeletal abnormalities can differ in severity from patient to patient, patterns
emerge wherein most patients diagnosed with SJS or DDSH have craniofacial abnormalities
specifically, with conditions like micrognathia (a small jaw with a receding chin) (20) manifest
in 30-79 percent of SJS patients and in 80-99 percent of DDSH patients (21,22). These
manifestations of chondrodysplasia (disorders in the development of cartilage and later, bone)
(23) suggest that mutations in HSPG2 play a disruptive role in craniofacial bone development.
Previous studies looking at tissue staining showed that mutations in HSPG2 cause
abnormal chondrocyte proliferation and arrangement (15). Chondrocytes are differentiated cells
found in cartilage, which later undergo the ossification process to become bone (24). Despite
these publications, however, not much has been elucidated on the mechanisms that tie together

4

how mutations in HSPG2 contribute to chondrocyte disorganization and how this phenomenon
manifests as craniofacial abnormalities.
THE NEURAL CREST CELL LINEAGE AND BONE DEVELOPMENT
To understand the development of the craniofacial skeleton, there must first be a cohesive
understanding of cellular development at the organism’s earliest stages. Upon fertilization, the
zygote undergoes cleavage and cell proliferation, the resulting cluster of cells is categorized as a
blastula (25). This blastula must then undergo a process known as gastrulation, an evolutionary
conserved set of movements which transform the single layer of the blastula into the
multilayered structure of the gastrula (25).
In the first defining gastrulation movement, cells which will later form the deepest germ
layer (the endoderm) and the middle germ layer (the mesoderm) undergo an epithelial to
mesenchymal transition (EMT). These cells move below a more superficial layer of cells (the
ectoderm) through an opening called the blastopore (in amniotic animals like humans, this is
called the primitive streak) (26). After these cells have moved inward, epibolic movements
evenly spread and thin the germ layers along the axis of the animal (26). In the third process,
known as convergence and extension, these three layers of cells elongate on the
anterior/posterior plane and narrow on the dorsal/ventral plane (26).
Following gastrulation, the embryo undergoes neurulation, otherwise known as the onset
of developing nervous system. During neurulation, a portion of the ectoderm (described in the
previous paragraph as the outermost germ layer) thickens into the neural plate and folds into the
future neural tube (27). Upon closure, the neural tube will eventually give rise to the structures of
the central nervous system. However, during neural tube closure, a subset of cells resident to the
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dorsal end of the neural tube will delaminate and adopt a migratory phenotype (the epithelial to
mesenchymal transition). These cells are known as neural crest cells (NCCs).
There are several derivative NCCs, which are classified into five distinct groups: trunk
NCCs, vagal NCCs, cardiac NCCs, sacral NCCs, and cranial NCCs (28,29). Trunk NCCs give
rise to neurons and glia that contribute to the periphery nervous system, vagal and sacral NCCs
generate the enteric ganglia of the gut, cardiac NCCs participate in the development of the heart
and cardiac ganglia, and cranial NCCs form craniofacial cartilage and bone (28,29). Of all four
populations of NCCs, cranial NCCs (CNCCs) are the only ones that develop into cartilage and
bone, making them vital to proper craniofacial skeletal development (30).
CNCCs migrate from hindbrain segments known as rhombomeres into the pharyngeal
region (31). The stream of CNCCs starts as a solitary, uniform wave before splitting into three
distinct, segregated streams, predominantly from rhombomeres 2, 4, and 6 (32). These three
streams enter structures known as the pharyngeal arches, a grouping of six arches conserved
across vertebrate species that are recognizable precursors for later craniofacial structures (32).
The first arch receives CNCCs from rhombomere 2 and develops maxillary and
mandibular swellings which will give rise to the midface and mandible (lower jaw). The second
arch receives CNCCs from rhombomere 4 and forms the stapes, the styloid process, and the
lesser horns of the hyoid bone. The third arch receives CNCCs from rhombomere 6 and forms
the hyoid body and the greater horns of the hyoid. The fourth and sixth arches (the fifth is not
included as it only exists temporarily during embryogenesis) both contribute to the laryngeal
cartilages (32).
Once these cells are situated in the pharyngeal arches, they begin to express
transcriptional factors like dlx2 and dlx5, a signal of their specification into the cranial lineage of
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NCCs, which will eventually differentiate into chondrocytes (28). CNCC cells play a role in both
intramembranous and endochondral ossification— a phenomena mediated by interactions with
various mesodermal-derived cells in their immediate environment (33). In intramembranous
ossification, CNCCs proliferate, condense into compact nodules, and become osteoblasts
(committed bone precursor cells) (34). These cells directly lay the foundational base for bone
growth. During the process of endochondral ossification, cells are first committed to become
cartilage by expressing transcriptional factors thought to activate cartilage specific genes (Pax1
and Scleraxis) (34–36). These committed cells then differentiate into chondrocytes (which
express transcriptional factors like col2a1) and rapidly proliferate before becoming hypertrophic
(37). Once these hypertrophic chondrocytes undergo apoptosis, osteoblasts begin forming bone
matrix on the degraded cartilage and create bone (34,38). This complex procedure shows that
NCCs are vital to craniofacial skeletal development and militainment.
ZEBRAFISH: A FUNCTIONAL MODEL FOR CRANIOFACIAL STUDIES
To understand the mechanisms underlying phenotypical abnormalities, researchers have
historically used an assembly of animal models. Over time, the zebrafish has emerged as a
complementary vertebrate model to the ubiquitous mus musculus, particularly in the
developmental field (13,39). General advantageous reasons to use zebrafish include their high
fecundity rate (about 200-300 embryos per clutch) and their external fertilization and
transparency (which gives ease to genetic manipulation and imaging without incurring invasive
procedures) (40). Additionally, craniofacial development employs the same embryologic
processes and molecular pathways in most vertebrate animals, meaning that zebrafish studies can
be translational to human development (41). This (coupled with their ease of use) makes them
ideal models for the research described in this defense.
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Complete sequencing of the zebrafish genome shows that they share 71 percent genetic
homology with humans; 82 percent of human genes with morbidity descriptions are found in
zebrafish as well (41). One such conserved gene is hspg2, the gene at the core of our research.
Perlecan-null mice (mimicking the DDSH phenotype) typically die at embryonic day 10-12 due
to mass hemorrhaging. This mass hemorrhaging is caused by increased mechanical stress (such
as myocardial contraction) further weakening the basement membrane around the heart wall
(42,43). This weakened connection between cardiomyocytes and surrounding endothelial cells
allows blood to leak into the pericardial cavity and embryos die of heart arrest (43).
Unlike the murine model, zebrafish with hspg2 knockdown does not cause hemorrhaging,
perhaps circumventing the lethality by obtaining the majority of their oxygen intake via diffusion
from their environment and not early cardiovascular function (13). There are currently
alternative tissue specific manipulations of hspg2 disruption, however these mice cannot be used
to analyze Hspg2 function during craniofacial development because they are created to express
hspg2 in chondrocytes to prevent lethal chondrodysplasia (44). Zebrafish likely circumvent this
by having longer lasting maternal deposition (zebrafish embryos are transcriptionally active at 10
cell cycles) than mice (which are transcriptionally active as early as the 1-cell stage and robust in
the 2-cell stage) (45–47). To lend credence to this, previous studies have shown that perlecan is
present as early as the 64 and 1000-cell stages, both timepoints before embryonic transcription
has begun (13).
In summation, the zebrafish model is ideal for studying how hspg2 mediates craniofacial
development. To explore the parameters of our patient case, we performed morpholino-mediated
knockdown of hspg2 in the zebrafish to examine resulting craniofacial phenotypes. Our initial
hypothesis was that a knockdown of hspg2 in the developing larvae would have a marked effect
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on craniofacial development and structure. The following results (comprising of results drawn
from WES, cell counts, qPCR, and in situ hybridization) support this hypothesis and suggest that
hspg2 regulates late stage NCC differentiation.
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Chapter 2: Identifying mutations in the human HSPG2 gene
METHODOLOGY
Subject DNA Extraction
The patient and parents were enrolled into a research protocol (COMRIB no. 07-0386)
approved by the institutional review board at the University of Colorado School of Medicine.
High quality, genomic DNA (A260/A280 ≥ 1.8 and A260/A230 ≥ 1.9) was extracted from whole
blood obtained from the patient and parents using the Puregene Blood kit from Qiagen
(Valencia, CA).
Whole Exome Sequencing and Data Analysis
Whole-exome sequencing was performed on the patient and his parents using service
provided by Beijing Genomics Institute (Cambridge, MA). Details of data analysis were similar
to procedure as previously described in Zhang et al, 2013 (48). Approximately 78 to 168 million,
100 bp, paired-end reads (>70X) were obtained and mapped to the reference human genome
(GRCh37/hg19) using Burrows-Wheeler Aligner (BWA) (49). Variants were determined by the
utilities in the SAMtools (49) and further annotated using SeattleSeq. Filtering and test of
inheritance model were done using tools in Galaxy (50).
Variants were filtered against dbSNP build 137, 1000 Genomes (2010 version), Exome
Variant Server (EVS, ESP6500SI-V2) and Exome Aggregation Consortium ExAC browser
(version 0.3). Rare variants were identified when their minor allele frequency (MAF) was less
than 1% using dbSNP137. The sequence data from the family was then used to test for causal
variants under different inheritance models, including de novo mutation in a dominant model and
compound heterozygous, homozygous and X-linked hemizygous mutations in recessive models.
Candidate genes were further evaluated based on different criteria in each model. In the
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dominant model, variants found in any database (dbSNP, 1000 Genomes, EVS, ExAC) were
removed from the top candidacy list. In the recessive model, autosomal variants which had
homozygotes found in the databases, such as EVS and ExAC, (or variants on chrX or chrY with
hemizygotes in databases) were also removed from the top candidacy list.
Sanger Sequencing
Genomic DNA from the subject and parents (100 ng) was amplified using a set of
primers (created in conjunction with Sigma (St. Louis, MO)) spanning HSPG2. The forward
primer created had the sequence 5’-CCCAAGGACACACTTCCACT-3’ and the reverse primer
had the sequence 5’-AGGCAGGGAAGGAGCATAAT-3’. Promega (Madison, WI) GoTaq
Green Master Mix and 10µM of each primer were used in the PCR master mix. The PCR began
with an initial cycle at 95ºC for 5 minutes, followed by 35 cycles of 95ºC for 30 seconds, 61ºC
for 30 seconds, and 72ºC for 1 minute, finishing with an extension at 72ºC for 5 minutes. The
amplified PCR products were sequenced using the PCR primers as sequencing primers. The
procedure was done on an Applied Biosystems Genetic Analyzer 3500 (Fisher, MA) with
Applied Biosystems associated software at the Genomic Analysis Core Facility in The
University of Texas at El Paso Border Biomedical Research Center.
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RESULTS
Whole Exome Sequencing shows compound heterozygous mutations
Based on previous published information that stated that 15-25% of MCAs have some
form of genetic etiology (4), it was hypothesized that the patient’s phenotypical abnormalities
were due to genetic mutations in the exome. Details of data analysis were previously described in
the Methodology section. The paired-end reads done at >70X coverage (on average, each base
was read by 70 sequences or more) were mapped to the reference human genome
(GRCh37/hg19) using Burrows-Wheeler Aligner (BWA). Results are shown in Table 1.1. The
coverage on the coding exon for the patient was 50.03, the mother was 93.38, and the father
63.10, respectively. The cutoff of this parameter lies at 50, meaning that the coverage (the
number of reads mapped to the patient genome) was accurate for all three samples (ie: all three
samples were evenly read and mapped) (51).
The variants were filtered against dbSNP137 (a database hosted by NCBI with a broad
collection of single nucleotide polymorphisms) (52) and Exome Aggregation Consortium ExAC
browser version 0.3 (dataset that aggregates data for allele frequencies that span 60,706 unrelated
individuals) (53). The patient had variants spanning various genes: a heterozygous de novo
mutation (a nonheritable mutation that has appears only in the patient) in the CLIP4 gene, a
homozygous mutation in the SDK1 gene, and two compound heterozygous mutations (two
mutations inherited from each parent in the same gene) in the SPTAN1 gene and the HSPG2 gene
(Table 1.2).
Of these variants, only HSPG2 has been linked to MCAs (SJS and DDSH) with
craniofacial abnormalities as a hallmark phenotype.
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Sanger Sequencing confirms compound heterozygous mutation in HSPG2
Results validated a c.5998-7A>G variant inherited from the mother in the noncoding
promoter region and a c.4916C>T variant found in a EGF laminin domain inherited from the
father (Figure 1.1). The father’s mutation produces the amino acid Thr1639Met. Using multiple
mutation prediction algorithms, it was predicted that this variant is deleterious (CADD: 29.1;
PolyPhen2 = probably damaging (1); PROVEAN = deleterious (-3.37); SIFT = damaging
(0.028); MutationTaster= disease causing (0.9999).

\
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Table 1.1: Paired end reads show exome reading accuracy
A table showing the results derived from using the Burrows-Wheeler Aligner software.
Listed are the patient and parents, the number of reads mapped to the coding and noncoding
regions, the percentage in the coding region, and the overall coverage on the coding exon.
Patient ID

Proband
Mother
Father

Reads
Mapped to
Coding Exon
23,645,253

Intergenic,
Intronic,
UTR%
46.84

Coding %
53.06

Coverage on
Coding
Exon (X)
50.03

43,943,738

54.18

45.82

93.38

29,917,122

59.06

40.94

63.10
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Table 1.2: Whole Exome Sequencing (WES) variants
A table showing the results obtained from WES. Listed are the positions of the mutations,
the type of mutations, the name of the gene they were found in, the minor allele frequency
(MAF) derived from each database, and the number of homozygotes in the databases.
Position

Type

Name
CLIP4

MAF
(dbSNP142)
0.00002

MAF
(ExAC)
0.000016

de novo
(chr2:29375616)

Heterozygous

Homozygous
(chr7:4091283)

Homozygous

SDK1

0.00879

0.005395

Compound
Heterozygous
(chr9:131341997)
Compound
Heterozygous
(chr9:131395079)
Compound
Heterozygous
(chr1:22181483)
Compound
Heterozygous
(chr1:22188289)

Heterozygous
(maternal)

SPTAN1

0.00158

0.00266

Heterozygous
(paternal)

SPTAN1

0.0006

0.000099

Heterozygous
(maternal)

HSPG2

0.00419

0.011

Heterozygous
(paternal)

HSPG2

15

0.0008

0.001318

Notes
No
homozygote
in database
17
homozygote
s in database
No
homozygote
in database
No
homozygote
in database
11
homozygote
s in database
No
homozygote
in database

A

B

Figure 1.1: Sanger Sequencing confirms WES
A) A diagram showing the mutations inherited from both parents in conjunction with sequencing
peaks (on the maternal end green and black overlapping peaks signify a base pair change from an
adenine to a guanine and on the paternal end red and blue overlapping peaks signify a base pair
change from a cytosine to a thymine). B) The intron-exon schema of the HSPG2 gene. Region
highlighted in red is where the maternal mutation is located relative to the sequence. Region
highlighted in green is where the paternal mutation is located relative to the sequence.
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Chapter 3: Antisense oligonucleotide morpholino knockdown of hspg2
PRELIMINARY RESULTS
Methodology
Animal Care
For all experiments, embryos were obtained by crossing adult Tg(sox10:tagRFP),
Tg(col2a1a:EGFP), and AB wildtype fish. Embryos were maintained in E3 embryo medium at
28˚C. All zebrafish were maintained at The University of Texas El Paso according to the
Institutional Animal Care and Use Committee (IACUC) guidelines protocol 811689-5.
Antisense oligonucleotide morpholino design and microinjection
Two antisense oligonucleotide morpholino sequences were designed in conjugation with
Gene Tool LLC. The first was a translation blocking morpholino (MO) with the sequence 5’TATCCTCGCCCCCATTTCTGCCAA-3’, created to bind to the hspg2 translation start site and
sterically knockdown perlecan translation in the developing larvae. The second was a random
control morpholino with the sequence 5’-AAAAAAAAAAAAAAAAAAAAAAAA-3’, used to
assure that the MO microinjections were not causing any form of cell death as described by
previous literature (54). When injecting, the clutch of embryos were separated into three groups
of equal numbers: the morphants (injected with the translation blocking MO), the random control
group (injected with the random control MO), and the wildtype siblings (non-injected). Both
MOs were injected into embryos at the one cell stage with a stock concentration of 0.10 µM and
at a volume of 0.52 nL per embryo. All embryos were kept as described above until needed.
Alcian Blue Staining
On the first day of the procedure, zebrafish larvae (aged 5 days post fertilization) were
fixed in 2% PFA in PBS, pH 7.5 for 1 hour at room temperature. Embryos were washed for 10
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minutes with 100mM Tris pH 7.5/10mM MgCl2 before the Alcian blue stain pH 7.5: 0.4%
Alcian blue (Anatech Ltd., MI) in 70% EtOH, Tris pH 7.5 (Fisher, MA), 1 M MgCl2 (Fisher,
MA), EtOH (Fisher, MA), and H2O was added and left overnight at room temperature. On day
two of the experiment, the embryos were destained and rehydrated using an EtOH: Tris pH 7.5
gradient. Embryos were bleached using a bleach solution: 30% H2O2 (Sigma, St. Louis, MO),
20% KOH (Fisher, MA) for 10 minutes. Samples were washed twice at 10 minutes per wash
with 25% glycerol/0.1% KOH (Fisher, MA). Embryos were then stored at 4ºC in 50%
glycerol/0.1% KOH (Fisher, MA) until measured. The distance between the Meckel’s cartilage
(an intermediate cartilaginous structure which makes up the ventral component of the mandibular
arch) (55) and the ceratohyal (a pharyngeal arch cartilage which makes up the largest component
of the ventral hyoid arch) (56) was measured for each embryo.
Transgenic animal lines and confocal microscopy
18 somite stage: Adult Tg(sox10: tagRFP) zebrafish were crossed and offspring were
split into two groups: one group was injected with the translation-blocking morpholino and
another was left uninjected as a wildtype control. Larvae were injected at the volume and
concentration as described above. Petri dishes with developing larvae were left at room
temperature overnight and monitored the following day. Larvae were fixed using 4%
paraformaldehyde at the 18-somite stage (aligning with early NCC specification and migration in
zebrafish). Fixed larvae were embedded on a dorsal plane in glass-bottomed plates using lowmelt agarose. Larvae were imaged at 20X magnification using a Zeiss LSM 700 Confocal
microscope with a 555 laser that exited the RFP reporter in sox10 (a transcriptional factor
expressed in NCCs) positive cells (39) . Maximum intensity projection images were processed
and saved.
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Prim-5 (1 dpf) stage: Adult Tg(sox10: tagRFP) zebrafish were crossed and offspring
were split into two groups: one group was injected with the translation-blocking morpholino and
another was left uninjected as a wildtype control. Larvae were injected as described above. Petri
dishes with developing larvae were left at 28 °C and monitored the following day. Larvae were
fixed using 4% paraformaldehyde at the Prim-5 stage (corresponding with NCCs migrating into
the pharyngeal arches at around 1 dpf). Larvae all had approximately 30 total somites. Fixed
larvae were embedded on a lateral plane in glass-bottomed plates using low-melt agarose. Larvae
were imaged at 20X magnification using a Zeiss LSM 700 Confocal microscope with a 555 laser
which exited the RFP reporter in sox10 (a transcriptional factor expressed in NCCs) positive
cells (39). Maximum intensity projection images were processed and saved.
Whole mount in situ hybridization and quantitative real time PCR
In situ hybridization: Whole mount in situ hybridization was performed as described by
Thisse and Thisse (57). Larvae were harvested and dechorionated at the Prim-5 (1 dpf) stage and
fixed in 4% paraformaldehyde (Electron Microscopy Sciences, PA) overnight at 4ºC. Larvae
were then dehydrated using a methanol: PBS gradient and stored in 100% methanol overnight at
-20°C. Embryos were rehydrated using a PBS:Methanol gradient, washed in PBS with 0.1%
Tween 20 and permeabilized with proteinase K (10ug/ml) for 10 minutes. Permeabilized larvae
were prehybridized for 2 hours in hybridization buffer (HB) which consists as follows: 50%
deionized formamide (Fisher, MA), 5X SSC (Fisher, MA), 0.1% Tween 20 (Fisher, MA), 50µg
heparin (Sigma, MO), 500µg of RNase-free tRNA (Sigma, MO), 1M citric acid (Fisher, MA),
and cell culture water. Larvae were then incubated overnight in fresh HB with an RNA probe
(dlx2a at 127 ng) at 70°. On the second day of the procedure, samples were washed according to
protocol, blocked in 2% sheep serum (Sigma, St. Louis, MO) and 2 mg ml-1 BSA (Sigma, St.
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Louis, MO) for 2 hours at room temperature. Samples were then incubated with anti-DIG
fragments (1:10,000) overnight at 4°C. On the third day, samples were developed with BM
purple AP substrate (Sigma, St. Louis, MO) and imaged with a Zeiss Discovery Stereo
Microscope fitted with Zen Software.
Quantitative PCR: For qPCR, RNA was isolated from embryos at 1 dpf with Trizol
(Fisher, MA) according to manufacturer’s protocol. Reverse transcription was performed using a
Verso cDNA Synthesis Kit (Fisher, WA) and PCR was performed using an Applied Biosystems
StepOne Plus machine with Applied Biosystems associated software. Sybr green (Fisher, MA)
based

primer

pairs

for

each

gene

analyzed

are

as

follows:

dlx2a

fwd

CCTCACGCAAACACAGGTTA, dlx2a rev TGTTCATTCTCTGGCTGTGC, rpl13a fwd
TCCCAGCTGCTCTCAAGATT, and rpl13a rev TTCTTGGAATAGCGCAGCTT. Statistical
analysis of mRNA expression was performed using a student’s two-tailed T-test, comparing the
random control and hspg2 morphant groups.
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Results
Morpholino-induced knockdown of hspg2 causes craniofacial phenotypes
Previous studies performed in the murine model showed that deletion of Hspg2 led to
failure of the chondro-osseous junction of developing bones (15). In these studies (where 40
percent of the animals died at embryonic day 10.5), the lateral skeletal bones of the mutants were
shorter, thicker, and misshapen when compared to wildtype mice. The remaining 60 percent of
animals died shortly after birth and were characterized by a narrow thorax and craniofacial
abnormalities. Based on these studies, we hypothesized that morpholino mediated knockdown of
the zebrafish hspg2 gene would cause craniofacial abnormalities as well. To test this, we
performed Alcian blue stain to detect developing cartilage. Measurements on the Alcian blue
stained embryos at 5 dpf (Figure 2.1) showed that the injection of the translation blocking
morpholino caused a 7% truncation in the zebrafish mandible when compared to the random
control and wildtype sibling groups. Stained embryos also demonstrated a fusion of the
mandibular jaw joint between the Meckel’s cartilage and palatoquadrate (the dorsal component
of the mandibular arch) (58) in the morphants, a phenotype not present in either the wildtype or
random control groups.
Neural crest cells migrate normally in the absence of hspg2
Because defects in the number of and migration of NCCs are possible mechanisms by
which craniofacial deficits may arise (39), we hypothesized that the craniofacial abnormalities
present at 5 dpf may have been due to hspg2 affecting early NCC specification and migration.
Images taken of hspg2 morphants and wildtype siblings at both the 18 somite and Prim-5 stages
(shown in Figure 2.2) showed no discernable differences between the sox10 positive NCCs in
either group at either timepoint.
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hspg2 does not regulate dlx2a expression in cranial neural crest cells
One possible explanation for the phenotypes observed in morphants could stem from
defects in CNCC specification. To determine if cells are specified into CNCCs properly, we
performed whole mount in situ hybridization to measure the expression of dlx2a at 1-day post
fertilization in random control and hspg2 morpholino injected embryos. The expression of dlx2a
(a homeobox gene) has been specified as a marker of proper CNCC specification at 1-day post
fertilization in previous studies (59–61). In situ hybridization (Figure 2.2) revealed that there was
no significant difference in the expression of dlx2a in morphants relative to random control
injected embryos. Collectively, these data suggest that early CNCC development was normal and
that the phenotypes we observed were likely caused by other mechanisms.
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hspg2 morphants (Mo)
A

B

Figure 2.1: Alcian blue staining reveals craniofacial phenotypes
(A) Dissected representative samples for the wildtype, random control, and morphant groups.
Ceratohyal, Meckel’s cartilage, and the palatoquadrate are shown as the abbreviations (ch), (mc),
and (pq) respectively. The black bar between the two shows the mandibular distance measured.
The black box on each of the images shows the jaw joint. (B) The truncation of the mandible
normalized to the random control group. The p-value shown pertains to the random control
group and morphants.
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Figure 2.2: hspg2 has no effect on early NCC migration or specification
Wildtype and morphant representatives at both the 18-somites stage and Prim-5 (~1 day post
fertilization (dpf)) stage showing lateral streams of migrating NCCs (18 somites stage) and
NCCs in the pharyngeal arches (labeled here 1-4) at the Prim-5 stage.
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A

hspg2 Morphants (Mo)

N=10

N=11

N=12

B

Figure 2.3: hspg2 knockdown has no effect on dlx2a expression
(A) in situ hybridization of dlx2a groups at 1-day post fertilization (1 dpf). (B) Quantitative PCR
expression of dlx2a in the random control and morphant groups at 1 dpf where each group has an
N=15.
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CURRENT RESULTS
Methodology
Alcian blue cell counts
The Alcian blue staining procedure was replicated at 5 dpf in the same manner as
described in the methodology section above. A representative sample of each group (hspg2
morphants, random control, and wildtype) was dissected and the viscerocranium (the mandibular
jaw region) was mounted on a glass slide with 100% glycerol. A Leica microscope was used to
take high-resolution color images of each sample and the chondrocytes at each jaw joint were
counted (3 rows of chondrocytes on the left side of the joint and 5 rows of chondrocytes on the
right). These numbers were selected because the left side of the developing jaw has a greater
amalgamation of chondrocytes than the right.
Transgenic animal lines and cell counts
Protruding mouth stage (3 dpf): Adult Tg(sox10: tagRFP) zebrafish were crossed and
offspring were split into three groups and injected as described above. Larvae were fixed using
4% paraformaldehyde at the protruding mouth stage (3 days post fertilization). All larvae were
fixed according to ideal length (3.5 mm to 3.7 mm) as described on the Zfin Developmental
Stages website (62). Larvae of each group were measured before and after fixation to assure all
were within ideal size range and the same developmental stage. Total N= 10/group. Samples
were then mounted on a ventral plane in glass-bottomed plates using low-melt agarose. Larvae
were imaged at 40X oil using a Zeiss LSM 700 Confocal microscope with a 555 laser which
exited the RFP reporter in sox10 (a transcriptional factor expressed in NCCs) positive cells (35).
20 to 30 z-stack slices were obtained and the number of cells per z-stack at each jaw joint region
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(3 rows of chondrocytes on the left side of the joint and 5 rows on the right) were counted using
ImageJ.
Four-days post fertilization (4 dpf) stage: Adult Tg(sox10: tagRFP) and
Tg(col2a1a:EGFP) zebrafish were incrossed and offspring were split into three groups and
injected as described above. Larvae were injected as described above. Larvae were fixed using
4% paraformaldehyde at approximately 4 dpf. All larvae were fixed according to ideal length
(3.7 mm to 3.9 mm) as described on the Zfin Developmental Stages website (62). Larvae of each
group were measured before and after fixation to assure all were within size range and the same
developmental stage. Representative samples (N=10) were then mounted on a ventral plane in
glass-bottomed plates using low-melt agarose. Larvae were imaged at 40X Oil using a Zeiss
LSM 700 Confocal microscope (the RFP larvae with the 555 laser and EGFP larvae with the 488
laser) which exited the RFP reporter in sox10 (a transcriptional factor expressed in NCCs)
positive cells and the GFP reporter in col2a1a (a transcriptional factor expressed in
chondrocytes), respectively (35). 20 to 30 z-stack slices were obtained and the number of cells
per z-stack at each jaw joint region (3 rows of chondrocytes on the left side of the joint and 5
rows on the right) were counted using ImageJ.
nkx3-2 mRNA quantification
In situ hybridization: Whole mount in situ hybridization was performed as described by
Thisse and Thisse (46). Larvae were harvested and dechorionated at the 2 dpf stage and fixed in
4% paraformaldehyde (Electron Microscopy Sciences, PA) overnight at 4ºC. Larvae were then
dehydrated using a methanol: PBS gradient and stored in 100% methanol overnight at -20°C.
Embryos were rehydrated using a PBS:Methanol gradient, washed in PBS with 0.1% Tween 20
and permeabilized with proteinase K (10ug/ml) for 10 minutes. Permeabilized larvae were
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prehybridized for 2 hours in hybridization buffer (HB) which consists as follows: 50% deionized
formamide (Fisher, MA), 5X SSC (Fisher, MA), 0.1% Tween 20 (Fisher, MA), 50µg heparin
(Sigma, MO), 500µg of RNase-free tRNA (Sigma, MO), 1M citric acid (Fisher, MA), and cell
culture water. Larvae were then incubated overnight in fresh HB with an RNA probe (dlx2a at
127 ng) at 70°. On the second day of the procedure, samples were washed according to protocol,
blocked in 2% sheep serum (Sigma, St. Louis, MO) and 2 mg ml-1 BSA (Sigma, St. Louis, MO)
for 2 hours at room temperature. Samples were then incubated with anti-DIG fragments
(1:10,000) overnight at 4°C. On the third day, samples were developed with BM purple AP
substrate (Sigma, St. Louis, MO) and imaged with a Zeiss Discovery Stereo Microscope fitted
with Zen Software.
Quantitative PCR: For qPCR, RNA was isolated from embryos at 1 dpf with Trizol
(Fisher, MA) according to manufacturer’s protocol. Reverse transcription was performed using a
Verso cDNA Synthesis Kit (Fisher, WA) and PCR was performed using an Applied Biosystems
StepOne Plus machine with Applied Biosystems associated software. Sybr green (Fisher, MA)
based

primer

pairs

for

each

gene

analyzed

are

as

follows:

nkx3-2

fwd

GCAGATTTAGCGGACGAGAC, nkx3-2 rev GCTTCAACCACCAGCGTTAT , rpl13a fwd
TCCCAGCTGCTCTCAAGATT, and rpl13a rev TTCTTGGAATAGCGCAGCTT. Statistical
analysis of mRNA expression was performed using a student’s two-tailed T-test, comparing the
random control and hspg2 morphant groups.
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Results
Alcian blue staining reveals a loss of chondrocytes at jaw joint
Due to the morphants exhibiting a fusion in the mandibular jaw joint at 5 dpf, a deeper
exploration of chondrocytes in the jaw joint at later developmental timepoints was needed. Based
on the initial Alcian blue staining results, we hypothesized that we would find an abnormal
arrangement of the chondrocytes in the mandibular jaw joint. Our replicated results (Figure 3.1)
uncovered that morphants had fewer chondrocytes at both developing jaw joints when compared
to the random control and wildtype groups. Despite the number of chondrocytes being decreased
in the morphant jaw joint, the fusion was still present, suggesting that in addition to mediating
cell differentiation, hspg2 also likely mediates chondrocyte arrangement in developing cartilage.
hspg2 knockdown affects chondrocytes at jaw joint
Early studies performed in a murine model showed that hspg2 knockdown decreased the
number of chondrocytes in skeletal tissue (15). This literature in conjunction with results from
earlier timepoints (18 somites and 1 dpf, discussed above in the preliminary data section), led us
to hypothesize that if hspg2 was not mediating early CNCC differentiation, that late stage
differentiation could be disrupted. To test this, we performed analysis of Sox10 positive cells at
3- and 4-days post fertilization. Sox10 is a generalized marker of NCCs and at later time points is
indicative of differentiation. At 3 dpf (Figure 3.2) morphants had a slight but statistically
significant increase of sox10:RFP positive cells in the mandibular jaw joint region. However, by
four days post fertilization, the number of Sox10 positive cells was reduced relative to control
injected embryos (Figure 3.3). Similar results were obtained when analyzing the number of
col2a1a positive cells from the Tg (col2a1a:EGFP) larvae (Figure 3.3). Collectively, these data
show a progressive loss of differentiated NCCs between 3 and 4 dpf.
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hspg2 affects nkx3.2 expression
nkx3.2 (also called bapx1) was first identified in the drosophila model and is part of the
NK family of homeobox genes (63). Homologues of the gene have been found in vertebrates
(including zebrafish and humans) and are dorsally expressed in the first pharyngeal arch where
the gene is essential for proper joint formation (63). Studies where the gene has been knocked
down show a fusion of the jaw joint (63). We hypothesized that by measuring the expression of
this gene on a transcriptional level, we could elucidate whether hspg2 directly regulates joint
development. In situ hybridization (Figure 3.4) demonstrate a decreased expression in the
morphant groups when compared to the random control and wildtype groups. These results were
quantified using qPCR (Figure 3.4).
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Upper: 45
Lower: 42

Upper: 43
Lower: 43

Upper: 36
Lower: 36

Figure 3.1: Alcian blue counts show a reduction of cells at the jaw joint
Representative samples of upper mandibular jaw joint in Alcian blue stained wildtype (WT),
Random control (RC), and hspg2 morphants (Mo) larvae. Number of chondrocytes counted (3
rows on the left side of the jaw and 5 rows on the right side of the jaw) in both joints shown
below each representative depiction. Upper here stands for upper jaw joint and lower stands for
lower jaw joint.

31

A

N=10

N=10

N=10

B

Figure 3.2: hspg2 mediates RFP positive cells at 3 dpf
(A) A figure showing a representative sample of each of the three groups (Wildtype, Random
control, and hspg2 morphants) at 3 days-post fertilization (3 dpf). (B) A bar graph showing the
normalized cell counts of RFP positive cells across all three groups. P-value pertains to the
statistically significant difference between the random control group and the morphants.
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A

N=10

N=10

N=10

B
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C

Figure 3.3: hspg2 mediates chondrocyte numbers at 4 dpf
(A) Representative Wildtype, Random control, and hspg2 morphant samples from transgenic
sox10:RFP and col2a1a:EGFP lines. (B) Normalized cell counts of EGFP positive cells across
Wildtype, Random control, and hspg2 morphant groups. P-value pertains to the statistically
significant difference between the Random control group and the morphants. (C) Normalized
cell counts of RFP positive cells across Wildtype, Random control, and hspg2 morphant groups.
P-value pertains to the statistically significant difference between the Random control group and
the morphants.
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A

.

B

Figure 3.4: nkx3.2 is decreased in hspg2 morphants
(A) Representative nkx3.2 in situ figures of Wildtype, Random control, and hspg2 morphant
groups at 2 days-post fertilization. (B) Quantitative PCR expression of nkx3.2 in the random
control and morphant groups.
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Chapter 4: hspg2 CRISPR Cas 9 Mutant
CRISPR CAS 9 CREATION AND INJECTION

Introduction
In zebrafish, morpholinos have been shown to have off-target effects (64). To validate the
morpholino experiments proposed, we used CRISPR/Cas9 to produce a stable, germline
mutation in hspg2.
The acronym CRISPR stands for clustered regularly interspaced short palindromic
repeats (65). These 29-nucleotide repeat sequences (separated by various 32-nucleotide spacer
sequences originating in phages and adopted as a form of host immunity) were first reported in
bacterial species. Partnering Cas enzymes were found to be highly conserved and adjacent to
these repeat sequences (65). Later studies decoded the mechanism by which Cas9 and CRISPR
RNA attack foreign DNA which matches that of the CRISPR sequences and found that this
system could be manipulated.
The specificity of the CRISPR/Cas9 system depends on the structure and conformation of
the Cas9 enzyme. This protein has two nucleic acid binding grooves: a large recognition (REC)
lobe and a small nuclease (NUC) lobe which houses two domains (RuvC and HNH) and a
protospacer-adjacent motif (PAM) interacting domain (65). When the enzyme is activated by a
designed single guide (sg) RNA binding to the REC lobe, it uses Watson-Crick binding between
the sgRNA and targeted DNA section to find a robust PAM site (NGG). Once the sgRNA is
anchored at the proper PAM site, the HNH domain cleaves the sgRNA-DNA bond while the
RuvC domain cleaves the other strand to form a double-strand break. These double strand breaks
are repaired through non-homologous end joining (NHEJ). NHEJ employs DNA ligase IV to re-
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join the broken ends, an operation that introduces insertion or deletion mutations (indels) into the
DNA. This ability means that NHEJ has advantages in knocking out genes (65).
Methodology
Designing CRISPR Targets
DESKGEN cloud (a website which finds and scores CRISPR target sites across various
genes) and PubMed nucleotide (a collection of genomic and transcript sequences from several
sources including GenBank) was used to design a target site that spanned all hspg2 variants at
the

earliest

location.

The

target

site

selected

has

the

sequence

5’-

GGCGAGACGGTCACAGTAGG-3’ and an activity score of 55 (where 35 is the cutoff for
target accuracy). Sequence was found in the mRNA transcript and a pair of oligos (5’TAGGCGAGACGGTCACAGTAGG-3’

and

3’-AAACCCTACTGTGACCGTCTCG-5’)

covering the target site were found using ZiFiT Targeter Version 4.2 (a software package that
identifies oligos for CRISPR target sites).
Creation of Plasmid for Cloning and Annealing Oligos
Plasmid Creation: A pDR274 glycerol stock was used to grow plasmids on a Kanamycin
resistant plate overnight at 37 °C. Two separate colonies were isolated overnight (18 hours) at 37
°C with shaking (225 RPM). Zymo plasmid miniprep kit (Irvine, CA) was used to extract
bacterial DNA. Bacterial DNA was linearized (done to allow oligo insertion into the plasmid
backbone) using Bsal-HF (New England Biolabs, MA) in a 37 °C water bath overnight. Cut
plasmid purified using a DNA Clean and Concentration kit from Zymo (Irvine, CA), run on a 1%
gel to assure enzyme functionality, and quantitated.
Annealing oligos: 3 µL of Oligos 1 and 2 (sequences listed above) were individually mixed with
5 µL10X T4 Ligase Buffer, 2 µL of PNK (Fisher, MA), and 40 µL of deionized water. Both
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reactions were incubated at 37°C for 30 minutes and then annealed using the following
parameters: 98 °C for 10 minutes, 70 °C for 20 minutes, and 37°C for 10 minutes. Annealed
oligos were diluted 1:1000 using deionized water and ran on a gel with linearized plasmid.
Oligos were quantitated and an online ligation calculator (66) was used to identify the amount of
linearized plasmid and oligo concentrations needed for a proper ligation.
Cloning Target DNA
Ligation reaction was completed with the following measurements: 1 µL of 10X T4
Ligase Buffer (New England Biolabs, MA), 1 µL of T4 DNA Ligase (New England Biolabs,
MA), 1 µL of linearized pDR274 vector DNA, 1µL of annealed oligos, and 5 µL of deionized
water. Ligation mix was left overnight at 4°C. The following day, 8 µL of ligation mix was
added to 50 µL of DH5α competent cells (New England Biolabs, MA) and mixed over ice for 30
minutes. Cells were heat shocked at 42°C for 20 seconds and then placed on ice for an additional
2 minutes. LB media was added and mixture was incubated at 37°C for 1 hour with shaking (225
RPM). 250 µL of transformed cell media was plated on Kanamycin-resistant plates and grown
overnight (18 hours) at 37°C. 8 resulting colonies were screened for positive insertion. Positive
colonies were sent for sequenced using an M13 fwd primer.
Creating sgRNA and Cas9 mRNA
Creating sgRNA: DNA from positive colonies was amplified via PCR and purified using
the Zymo DNA Clean and Concentration Kit (Irvine, CA). Purified DNA was quantitated and
synthesized into RNA using a T7 RNA polymerase kit from New England Biolabs (MA) in the
following reaction mix: 100-500ng of purified PCR product, 2 µL of 10x T7 polymerase
transcription buffer, 2 µl NTP mix, 1 µL RNase inhibitor, 2 µL T7 RNA polymerase, and 3 µL
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of nuclease-free H2O. Reaction was left at 37° C overnight. Resulting RNA was purified using
phenolchloroform and quantitated. 117.9 ng/µL aliquots were saved at -80°C.
Linearizing Cas9 mRNA: Glycerol stock sample of Cas9 (a protein related to the CRISPR
mechaniscs) was grown and isolated as described above in plasmid creation section. Cas9 culture
was isolated, extracted, and digested using the XBal enzyme from New England Biolabs (MA).
Resulting RNA was purified using isopropanol washes.
Injection of Zebrafish Embryos
The following components were combined into a 10 µL reaction to inject into one-cell
embryos: 4 µL of KCl (used here to aid embryo survival), 1 µL of Phenol red, 1 µL of 500 ng
Cas9 mRNA, 1µL of 70 ng sgRNA, and 3 µL of deionized water. Embryos were injected as
described in Chapter 3.
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CRISPR CAS 9 VALIDATION

Methodology
DNA Isolation and PCR
Injected larvae were grown to adulthood. At approximately one year of age, DNA from
each individual fish was extracted via fin clip and a series of phenolcholorform and ethanol
washes. PCR primers that flank the genomic CRISPR target site were designed with the
following sequences: hspg2 fwd (5’-TTCGCACTGAATGAATCTGC-3’) and hspg2 rev (5’GGGCACACCAATAGCAGAAC-3’). The PCR parameters were as follows: 95ºC for 5
minutes, followed by 35 cycles of 95ºC for 45 seconds, 60ºC for 30 seconds, and 72ºC for 30
seconds, finishing with an extension at 72ºC for 5 minutes.
T7 endonuclease digest
PCR was performed on DNA extracted from 24 injected fish using previously described
hspg2 primers. Additional DNA was extracted from 3 wildtype AB fish and 25 reactions were
amplified using the same primer pair set. The reaction mix per tube was as follows: 5µL of a
wildtype PCR reaction and 5 µL of potential CRISPR mutant PCR reaction (for samples 1-24),
10 µL of wildtype PCR reaction (negative control), and 5µL of hcfc1a PCR reaction and 5µL of
wildtype PCR reaction (positive control). These samples were heated at 10 minutes for 95°C and
then incubated at room temperature for 1 hour to reanneal DNA. After a 1-hour room
temperature incubation, a cocktail of 1 µL of T7 Endonuclease enzyme, 2 µL of 10X buffer, and
7 µL of deionized water were added to each tube. Samples were analyzed for digestion on a 3%
gel.
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DNA ligation and sequencing
DNA from a potential screened mutant was ligated into DH5α component cells using a
pGEM t-easy kit (Promega, WI). 8 colonies were selected and screened using the hsgp2 primer
pair described above. Positive samples were sent to sequence using the hspg2 forward primer
and fasta sequences were analyzed for possible mutations.
Wildtype outcross and the F1 generation
Potential founder mutant was outcrossed with a male wildtype fish in a 1 by 1 cross.
DNA was extracted from 30 larvae at 2 dpf and amplified using the hspg2 primer pair. Larvae
DNA was screened using the T7 endonuclease assay in the same procedure as listed above. DNA
of putative mutants was sequenced.

41

Results
T7 Endonuclease assay shows potential mutant
We utilized the T7E1 (T7 Endonuclease I) assay to screen for putative CRISPR-induced
mutants. This assay is commonly used as an easy-to-interpret and cost-effective way of
validating CRISPR-induced mutations (67). In bacteriophages, T7EI resolves branched DNA by
cutting at the 5’ base of cruciform DNA structures (67). When used in the T7E1 assay, the
endonuclease will cut at sites where it recognizes a mismatched duplex structure. In this assay,
both sample DNA and wildtype DNA are annealed to create a sequence that mimics a
heterozygous mutation, which the enzyme will recognize and cleave. Samples 1-24 were
compared to the wildtype negative control and an hcfc1a positive control with uncut samples
having the same band size (285 bp) as the wildtype. Results (Figure 4.1) revealed seven possible
mutants: Fishes 1, 3, 5, 7, 9, 11, 12, and 16. All seven PCR samples (about 5 µL each) were sent
for sequencing along with the forward hspg2 primer. Sanger sequencing results revealed that
only fish 11 had a putative mutation within the amplified CRISPR target site.
Ligated colonies show two putative mutations within CRISPR target site
After Sanger sequencing results revealed a potential founder, we planned to confirm
these data by ligating the putative founder’s DNA into competent cells where changes in the
target site sequence could be more readily analyzed. We hypothesized that we would detect a
germline mutation from ligated bacterial colonies. Of the nine colonies screened, only seven
contained the hspg2 insert and these were each sequenced. Sequencing revealed distinct
sequential changes in the CRISPR target site: a 4-bp deletion (CCTA) and a 2-bp insertion (CG)
respectfully.
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F1 generational outcross does not reveal a germline mutation
Because CRISPR injections tend to create mosaic mutations in different cell populations
of the tested animal (and particularly so in zebrafish) (69), the only way to test if a putative
mutation in the founder reached the germline would be to outcross the fish and test the potential
F1 offspring. Results from the T7 digest showed five potential germline mutants. DNA from
offspring were sent for Sanger sequencing and results did not show any abnormalities within the
CRISPR target site, leading us to the conclusion that the initial discrepancies shown in the
sequences from the colony ligations were mosaic mutations located in the caudal fin cell
populations which did not achieve germline status.
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Figure 4.1: T7 digest reveals potential founder
Representative sample for 3% gel ran on T7 endonuclease assay. In figure, WT= wildtype and
MT= mutant, with samples 1 through 11 representing the putative mutants tested. Numbers in
red show the samples sent for sequencing. All samples selected differed from the wildtype (WT)
by having two extraneous bands.
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Chapter 5: Discussion
WES results for our patient case presenting with craniofacial abnormalities revealed an
inherited compound heterozygous mutation in the HSPG2 gene. Previous literature described
craniofacial deficits as a hallmark phenotype of SJS and DDSH, two multiple congenital
anomalies strongly linked to mutations in the HSPG2 gene (21,22). Despite these parallels, very
little is known about the mechanisms by which HSPG2 regulates cartilaginous development.
With the data described in this defense, we expand upon previously published work by
identifying the complex role hspg2 has regarding craniofacial development, particularly in the
temporomandibular joint region.
Previous studies describing Hspg2 knockouts in the murine model (15,18) confirmed that
the Hspg2 gene played a vital role in craniofacial development by reporting newly born hspg2-/mice with truncated snouts and mandibles. Our initial Alcian blue stain results showed a similar
phenotype, with a 7% mandibular truncation between the Meckel’s cartilage and ceratohyal
(analogous to the mandibular region) in the hspg2 morphants. These results exemplify a
correlation between our gene of interest and our resulting phenotype, which has been strongly
supported by previous published literature (16–19,68–70).
Furthermore, we identified the presence of temporomandibular joint fusions in the
morphant group. While patient cases have listed joint contractures in major joints as a common
phenotype in SJS and DDSH patients (21,69–71), very little has been reported on this phenotype
being present in the craniofacial region. In fact, in current published literature, there has been
only one case report found that has shown that both craniofacial phenotypes (micrognathia) and
limited range of motion in the jaw are present in patients with SJS (72). Although relatively
novel, the idea of hspg2 mediating the temporomandibular region is not completely unfounded.
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Similar to all other diarthrodial joints in the human body, the temporomandibular joint contains a
synovial capsule, which, in previous cell culture work, has been implicated to contain perlecan
(73,74), the protein output of hspg2. Conclusively, although this jaw fusion in our morphants
provides innovation to the field, it barely begins to introduce the role that HSPG2 plays in
mediating proper temporomandibular joint development and further studies would need to be
completed to draw more concrete conclusions.
Previous studies (15,18) also revealed that knockout of Hspg2 leads to abnormal
chondrocyte arrangement and a loss of chondrocytes in hypertrophic zones of the appendicular
skeleton. This lead us to the possible conclusion that mutations in hspg2 could initiate
temporomandibular abnormalities though the neural crest cell (NCC) lineage. Literature states
that cells of the neural crest lineage must undergo a series of steps including specification,
migration, proliferation, and differentiation in order to produce the cartilaginous structures of the
face and neck (71,72). In this defense, we focused on the cranial neural crest cells (CNCCs) as
these are the only NCC linage that lead to the formation of cartilage and bone in the craniofacial
region (14). Nevertheless, a small concentration of morphants still presented with phenotypes
like cardiac edema and pigmentation defects at 2 dpf, possibly suggesting a role for hspg2 in
various NCC lineages.
Results showing a decrease in col2a1a+ (a transcription factor expressed in mature
chondrocytes) cells at the temporomandibular joint at 4 dpf morphants implies that hspg2 plays a
mediating role in CNCC differentiation, something which is supported by sox10+ counts at the
same time point. Studies suggest that perlecan (Hspg2-/-) deficient mice display an abnormal
arrangement and proliferation of chondrocytes in the lateral skeleton (73). On a superficial level,
these results match our obtained data, but gaps between the two still remain. The cells of the
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appendicular skeleton derive from the mesoderm germ layer, not the ectoderm like the cells of
the craniofacial skeleton (74). Although both lineages give rise to cartilaginous structures, the
transcriptional factors that regulate skeletal development may play significantly different roles in
the cells of each lineage. Additionally, the results we obtained from the sox10+ cells in the same
region at 3 dpf (an increased number in the morphants relative to the random control group)
seem to directly counter the results at 4 dpf. To fully elucidate how hspg2 is regulating the
chondrocyte development in those regions, future studies would have to entail measurements of
CNCC proliferation (through use of methods like 5-bromo-2´-deoxyuridine (BrdU pulse
labeling) and CNCC apoptosis (through use of Terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) staining) (75,76).
As a departure from examining the cells of the CNCC lineage, we measured the
expression of a transcription factor known as nkx3.2. Nkx3.2 is a transcription factor expressed in
pharyngeal arch one and it has been found in previous morpholino studies to align to proper
temporomandibular joint development (63). We found that knockdown of hspg2 causes
chondrocyte dysregulation because chondrocytes filled the space of the developing joint, causing
a fusion between the two bones. These results (in conjunction with the Alcian blue stain that
revealed a temporomandibular fusion in the hspg2 morphants) compelled us to use nkx3.2 as a
marker for jaw development.
Our results showed that a knockdown of hspg2 reduced expression of nkx3.2 as well.
These results, when understood in the context of the decrease of col2a1a+ cells found at 4 dpf,
appear to match previous results done in mesenchymal cell culture which state that nkx3-2
upregulates col2a1 by directly binding to it (77). In this situation, diminishing the levels of nkx32 appear to downregulate the expression of col2a1a and the differentiation of cells into
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chondrocytes. Inversely, these results do not correlate to work done in the developing chick
which states that nkx3-2 is a negative regulator of chondrocyte maturation which, when knocked
down, leads to an overproliferation of chondrocytes (78). Discrepancies in the results could be
due to differences in the model used (although it is noted that the environment of the cell culture
will not readily capitulate the dynamic environment that an in vivo model will) (79).
Furthermore, these results which appear to match those that we received (the cell culture results)
were performed in mesenchymal cells and not cells from an ectoderm lineage. To garner more
consistent results, we would have to plan future studies where sox10 and col2a1a are being
measured quantitatively, perhaps with mRNA quantification taken at the 3 and 4 dpf stages.
An additional experimental technique would be to study the interaction between hspg2
knockdown and edn1, a gene that encodes for a vasoconstrictor and is expressed in pharyngeal
arch ectoderm, mesoderm, and endoderm (80,81). Edn1 acts through its cognate type-A receptor
(Ednra) to promote ventral skeletal fates and lower-jaw formation (81). Edn1 has been reported
to bind to nkx3.2 and directly mediates its function (ie: expression of edn1 is required for nkx3-2
expression) (80).
As has been shown so far, the zebrafish is an ideal animal model to study the role of
hspg2 in craniofacial development. Induced knockouts (mimicking the null mutations associated
with DDSH patients) in the murine model have resulted in embryonic lethality through mass
hemorrhaging in the pericardial cavity, an occurrence which can be temporarily circumvented in
the developing zebrafish (13). Subsequently, current mice models which survive to adulthood
cannot be used to study skeletal development either because hspg2 has been rescued in
chondrocytes to prevent lethal chondrodysplasia (44).
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In addition to the fish not requiring early mechanical heart function to obtain necessary
oxygen intake (13), zebrafish generally make ideal models for lethal mutations due to their
external fertilization and rapid development (82). Although cross-species staging comparisons
are incredibly difficult to match, it can be implied that the murine embryonic day 10-12 time
frame is analogous to the zebrafish pharyngula stages (1-2 dpf) through the larval protruding
mouth stage (3 dpf) (83,84), both timepoints that have already undergone significant craniofacial
development and can be easily monitored (62).
Nevertheless, all the work that has been reported using the zebrafish in this defense has
been completed by use of a translation-blocking morpholino. While translation-blocking
morpholinos are a simple and effective way in which to knockdown genes of choice, they tend to
have off target effects and can be implicated in cell death via activation of p53 (54). In fact, it
has also been reported that the phenotypes present in morphants very rarely match up with those
present in a germline mutant (85).
We did, however, utilize a random control morpholino to account for the possibility of
morpholino-induced cell death— an endeavor which proved to be rather successful (experiments
performed did not show a discrepancy between the wildtype and random control groups). For
future experiments, we plan on utilizing more than one morpholino control. A splice-site
morpholino can aid us in mimicking the patient mutation more readily and a p53 morpholino can
be co-injected to measure neural toxicity in a more accurate context (86).
Despite the use of morpholinos, the best manner in which you can test the true effect of
genes implicated in disease is by creating a germline mutant. By creating a mutant, you can more
readily rid yourself of off-target effects by breeding out the founder generation. Overall, our
attempts of creating a CRISPR Cas9 mutant were unsuccessful and given the tendency for
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CRISPR Cas9 to induce mutations at random, it is unlikely that we could have managed to create
a germline mutation that replicated those found in the patient case. However, we predict future
attempts will be successful to introduce nonsense mutations.
Conclusively, our results managed to create novel implications for the general association
of hspg2 in context of the development of the temporomandibular joint, a region of the
craniofacial skeleton for which development has not been well elucidated. Our preliminary data
concerning late CNCC differentiation raises pertinent questions about the fate of certain cells
within different areas of the developing face. Further studies that elucidate the role of hspg2 in
skeletal development are warranted.
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